B. Shaw

发表

Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes

D. Gemsa, H. Sprenger, A. Kaufmann, 2003, Journal of leukocyte biology.

Independent interactions of ubiquitin-binding domains in a ubiquitin-mediated ternary complex.

J. Strachan, M. Searle, R. Layfield, 2011, Biochemistry.

Inhibition of cullin RING ligases by cycle inhibiting factor: evidence for interference with Nedd8-induced conformational control.

M. Searle, R. Layfield, T. Hagen, 2011, Journal of molecular biology.

Validation of proteomic biomarkers previously found to be differentially expressed in women with Polycystic Ovary Syndrome: a cross-sectional study

C. Hodgman, R. Layfield, C. Daykin, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ubiquitin-mediated signalling and Paget's disease of bone

R. Layfield, B. Shaw, 2007, BMC Biochemistry.

Broad Utility of an Affinity-enrichment Strategy for Unanchored Polyubiquitin Chains

A. Jacobson, D. Skowyra, N. Oldham, 2014 .

Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function

F. Gianfrancesco, T. Esposito, S. Ralston, 2014, Biochimica et biophysica acta.

Sequestosome 1 Mutations in Paget's Disease of Bone in Australia: Prevalence, Genotype/Phenotype Correlation, and a Novel Non‐UBA Domain Mutation (P364S) Associated With Increased NF‐κB Signaling Without Loss of Ubiquitin Binding

J. Walsh, A. Magno, Jiake Xu, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Characterization of a Non‐UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone

M. Brandi, M. Searle, R. Layfield, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling

M. Searle, R. Layfield, B. Shaw, 2016, Molecular and Cellular Neuroscience.

Sequestosome 1 mutations in Paget's disease of bone in Australia: Prevalence, genotype/phenotype correlation and a novel non-UBA domain mutation (P364S) associated with increased NF-κB signalling without loss of ubiquitin-binding

J. Walsh, A. Magno, Jiake Xu, 2009 .

Knockdown of alpha myosin heavy chain disrupts the cytoskeleton and leads to multiple defects during chick cardiogenesis

R. Layfield, S. Loughna, Catrin Rutland, 2009, Journal of anatomy.

Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD

Robert Layfield, Terje Johansen, Barry Shaw, 2016, Autophagy.

Molecular insights into an ancient form of Paget’s disease of bone

W. Fraser, R. Fischer, S. González, 2019, Proceedings of the National Academy of Sciences.

Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling.

M. Williamson, M. Searle, R. Layfield, 2010, Journal of molecular biology.

The action of sodium salicylate and aspirin on some kallikrein systems.

B. Shaw, P. Hebborn, 1963, British journal of pharmacology and chemotherapy.

Biocomposites of non-crosslinked natural and synthetic polymers.

A. Coombes, S. Downes, B. Shaw, 2002, Biomaterials.

Structural insights into specificity and diversity in mechanisms of ubiquitin recognition by ubiquitin-binding domains.

J. Strachan, M. Searle, R. Layfield, 2012, Biochemical Society transactions.